coronary heart disease Heart and Vascular disease
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Healthy persons within the age group of 18-60 years.
Exclusion criteria
Exclusion criteria: Use of ACE inhibitors, AT1 receptor blocker or renin inhibitor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in gene-expression of inflammatory genes in response to bradykinin B1 receptor stimulation in human mononuclear cells in the presence or absence of the rs12050217 minor allele. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary study parameters are to test if the inflammatory response is influenced by stimulation or inhibition of other components of the RAS or kinin system and evaluation of the plasma for the presence of inflammatory cytokines and RAS hormones. In addition, genetic analysis of other SNP*s in the RAS and kinin system in relation to the inflammatory response is also a secondary measurement. | — |
Countries
Netherlands
Outcome results
None listed